Vaccinex, Inc. (VCNX) Return on equity 2021–2022
Vaccinex, Inc. (VCNX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-381.6%FY2022 · since FY2021: -301.9% → -381.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -381.6% | -79.6 pp |
| FY2021 | -301.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More VCNX financial trends
VCNX RevenueVCNX Net incomeVCNX Net marginVCNX Gross profitVCNX Gross marginVCNX Operating incomeVCNX Operating marginVCNX Operating cash flowVCNX Free cash flowVCNX Capital expendituresVCNX Stock buybacksVCNX Dividends paidVCNX Total assetsVCNX Total liabilitiesVCNX Shareholders’ equityVCNX overview →